You are reading 1 of 2 free-access articles allowed for 30 days
The recommendations will then be brought to the HSE Social Inclusion Governance Group (SIGG) “to inform an appropriate procurement process” before the SIF is opened in Dublin city centre.
The Medical Independent (MI) website (www.mindo.ie) is currently hosting an online poll asking readers if they would work as a healthcare professional at a SIF for drug users.
A Department spokesperson told MI: “The HSE has been tasked with establishing the SIF in 2017 and has established a working group to gather data, consider possible options and to undertake public consultation before any decision is made. Local stakeholder engagement and consultation will be critical to the success of any pilot facility.
“The Department of Health has been informed that the HSE working group will make recommendations on programme design and governance structures to the HSE Social Inclusion Governance Group (SIGG) to inform an appropriate procurement process.
“The HSE intends to look for expressions of interest in early autumn from those interested in operating this facility.”
According to the HSE, it is anticipated that the pilot service will be open before the end of 2017.
The HSE’s spokesperson did not provide any more information regarding the proposed role of doctors, but pointed this newspaper towards a new section on its website titled ‘Frequently Asked Questions: Supervised Injecting Facilities’.
According to this web page, the Executive is working on a recommendation for a “model of best practice”.
“This best practice model will include monitoring and evaluation, in addition to the delivery of the service. A procurement process will be undertaken to determine the most appropriate organisation to manage the facility and the specifications and criteria for the SIF are being developed.
“The organisation that is selected to provide the service will be expected to provide a location and have a robust community engagement plan in their operational set-up. Locating the facility in an area where public injecting is already taking place will maximise uptake by the target population.”
The Misuse of Drugs (Supervised Injecting Facilities) Act 2017 was signed by the President on 16 May 2017.